Pequit, Laura C.
HRN: 25-17-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2024
CEFTRIAXONE 1G (VIAL)
06/03/2024
06/09/2024
IV
2gm
Q24
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes